The European Commission has released details of the first projects to receive support under the Innovative Medicines Initiative (IMI) Joint Technology Initiative (JTI). The 15 projects will share a EUR 246 million funding pot. EUR 110 million of this will come from the Seventh Framework Programme (FP7), while the pharmaceutical industry will provide the remaining EUR 136 million through in kind contributions (e.g. staff, laboratory facilities, materials and clinical research).
Read more ...